Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806-8012
    BD:
    East and South China:Ms. Gu 15378638068
    North China, East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department:0512-69998806-8022
    Tumor business:0512-69998806-8058
    Non tumor business:0512-69998806-8026
    Pathogenic microorganism business:0512-69998806-8037
    Integrated Service Platform:0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key model for drug development of primary sclerosing cholangitis

  Primary sclerosing cholangitis (PSCH) is a chronic cholestatic disease characterized by progressive inflammation and fibrosis of the intra- and extrahepatic bile ducts, which in turn leads to multifocal bile duct strictures. Most patients eventually develop cirrhosis, portal hypertension and hepatic decompensation.
  We have established a stable model of trinitrobenzene sulfonic acid (TNBS)-induced primary sclerosing cholangitis , which is suitable for preclinical studies of drugs for primary sclerosing cholangitis and evaluation of new drugs.
  Please contact us for your project needs and to experience more of our professional services.

Our services

Model classification

Model Name

Animal species

Primary sclerosing cholangitis

Model of primary sclerosing cholangitis induced by trinitrobenzene sulfonic acid (TNBS)

Rats


Case sharing

Next:Acute pancreatitis